Oncotarget

Research Papers:

Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study

Luana Mota Martins, Carla Solange de Melo Escorcio Dourado, Larysse Maira Campos-Verdes, Fabiane Araújo Sampaio, Camila Maria Simplício Revoredo, Danylo Rafhael Costa-Silva, Maria da Conceição Barros-Oliveira, Elmo de Jesus Nery Junior, Lucia Maria do Rego-Medeiros, Luiz Henrique Gebrim, Francisco Adelton Alves-Ribeiro, Gilmara Péres Rodrigues, Diego Cipriano Chagas, Dilina do Nascimento Marreiro and Benedito Borges da Silva

PDF  |  Full Text  |  How to cite  |  Order a Reprint

Oncotarget. 2019; 10:6879-6884. https://doi.org/10.18632/oncotarget.27347

Metrics: PDF 484 views  |   Full Text 674 views  |   ?  


Abstract

Luana Mota Martins1, Carla Solange de Melo Escorcio Dourado1, Larysse Maira Campos-Verdes1, Fabiane Araújo Sampaio1, Camila Maria Simplício Revoredo1, Danylo Rafhael Costa-Silva1, Maria da Conceição Barros-Oliveira1, Elmo de Jesus Nery Junior1, Lucia Maria do Rego-Medeiros2, Luiz Henrique Gebrim1, Francisco Adelton Alves-Ribeiro1, Gilmara Péres Rodrigues1, Diego Cipriano Chagas1, Dilina do Nascimento Marreiro1 and Benedito Borges da Silva1,2

1 Postgraduate Program, Northeast Biotechnology Network (RENORBIO), Biotechnology in Health, Federal University of Piaui, Teresina, Piaui 64000-020, Brazil

2 Facid / Wyden Differential Integral Medicine Faculty, Department of Mastology, Teresina, Piaui 64052-810, Brazill

Correspondence to:

Benedito Borges da Silva,email: beneditoborges@globo.com

Keywords: breast neoplasms; fibroadenoma; matrix metalloproteinase-2; matrix metalloproteinase-9; immunohistochemistry

Received: September 17, 2019     Accepted: November 06, 2019     Published: December 03, 2019

ABSTRACT

Background

Matrix metalloproteinases (MMPs) 2 and 9 may play an important role in cell proliferation and dissemination of cancer. However, few studies have compared the expression of these proteins between breast cancer and fibroadenoma.

Material and methods

A randomized, double-blind study was carried out in 66 premenopausal women, aged 20-49 years, who had been diagnosed with fibroadenoma or breast cancer. The patients were divided into two groups: Group A, control (fibroadenoma, n=36) and Group B, study (cancer, n=30). Immunohistochemical analysis was performed using tissue samples of fibroadenoma and breast cancer to assess MMP-2 and MMP-9 antigen expression. Cells were considered positive if exhibiting brown cytoplasmic staining. Fisher’s exact test was used to compare the percentage of cases with cells expressing MMP-2 and MMP-9 in control and study groups (p < 0.05).

Results

Light microscopy showed a higher concentration of cells with positive cytoplasmic staining for MMP-2 and MMP-9 expression in breast cancer than in fibroadenoma. The percentage of cases with cells expressing MMP-2 in the control and study groups was 41.67% and 86.11%, respectively (p < 0.0009), whereas the percentage of cases with cells expressing MMP-9 in groups A and B was 66.67% and 93.33%, respectively (p<0.0138). MMP-2 and MMP-9 positive expression was significantly higher in moderately differentiated tumors compared to well and poorly differentiated tumors, p <0.005 and p<0.001, respectively.

Conclusions

The current study shows that MMP-2 and MMP-9 protein expression was significantly higher in the breast cancer than in the fibroadenoma and also in moderately differentiated breast cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27347